Redeye updates on Stillfront following the company's Q1-results which were in line with our expectations. The company leaves its outlook is unchanged and while we have slightly lowered near-term organic growth we still expect it to sequentially improve over the coming quarters.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/